Paula Llabata

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 3

Top Topics

Signaling Pathway

Circulating Tumor Cells

Top Venues

Molecular cancer research : MCR

Proceedings of the National Academy of Sciences of the United States of America

Nature communications

Universitat de Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Universitat de Barcelona Sep 15 2015

Spain

PHD

Universitat Autònoma de Barcelona Sep 01 2014 - Jul 15 2015

Spain

MSC

Universitat Politècnica de València Sep 01 2009 - Jul 01 2014

Spain

BSC

Publications

Octavio A Romero, Andrea Vilarrubi, Juan J Alburquerque-Bejar, Antonio Gómez, Alvaro Andrades, Deborah Trastulli, Eva Pros, Fernando Setien, Sara Verdura, Lourdes Farre, Juan F Martín-Tejera, Paula Llabata, Ana Oaknin, Maria Saigí, Josep M Piulats, Xavier Matias-Guiu, Pedro P Medina, August Vidal Bel, Alberto Villanueva, Montse Sanchez-Cespedes
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade. Nature communications 12 (1) (2021)
Paula Llabata, Manuel Torres-Diz, Antonio Gómez, Laureano Tomás-Daza, Octavio A Romero, Joaquím Grego-Bessa, Pere Llinas-Arias, Alfonso Valencia, Manel Esteller, Biola-Maria Javierre, Xiaoyang Zhang, Montse Sanchez-Cespedes
MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex. Proceedings of the National Academy of Sciences of the United States of America 118 (37) (2021)
Paula Llabata, Yoichiro Mitsuishi, Peter S Choi, Diana Cai, Joshua M Francis, Manuel Torres-Diz, Namrata D Udeshi, Lior Golomb, Zhong Wu, Jin Zhou, Tanya Svinkina, Estrella Aguilera-Jimenez, Yanli Liu, Steven A Carr, Montse Sanchez-Cespedes, Matthew Meyerson, Xiaoyang Zhang
Multi-Omics Analysis Identifies MGA as a Negative Regulator of the MYC Pathway in Lung Adenocarcinoma. Molecular cancer research : MCR 18 (4) (2019)